SCHEMBL30121445

SCHEMBL30121445

CN(C)[C@H]1CCc2ccc(Nc3nc(N)n(-c4cc5c(nn4)-c4ccccc4CCC5)n3)cc2CC1

nearest known ligand 0.77

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AXL P30530 15/20 0.77
FLT3 P36888 6/20 0.77
KIT P10721 3/20 0.77
AURKA O14965 2/20 0.77
EGFR P00533 1/20 0.77
RET P07949 1/20 0.77
MET P08581 1/20 0.77
SRC P12931 1/20 0.77
PDGFRA P16234 1/20 0.77
KDR P35968 1/20 0.77
TYRO3 Q06418 1/20 0.77
DDR1 Q08345 1/20 0.77
MERTK Q12866 1/20 0.77
AURKB Q96GD4 1/20 0.77
ALK Q9UM73 1/20 0.77
JAK2 O60674 1/20 0.37
IRAK4 Q9NWZ3 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2056599 1.00 AXL (0.77) AXLFLT3KITAURKAEGFR
SCHEMBL467995 1.00 AXL (0.77) AXLFLT3KITAURKAEGFR
SCHEMBL30121573 0.91 AXL (0.73) AXLFLT3KITAURKAEGFR
SCHEMBL1638518 0.91 AXL (0.73) AXLFLT3KITAURKAEGFR
SCHEMBL2056499 0.91 AXL (0.73) AXLFLT3KITAURKAEGFR
SCHEMBL30090865 0.91 AXL (0.73) AXLFLT3KITAURKAEGFR
SCHEMBL1639408 0.91 AXL (0.80) AXLFLT3KITAURKAEGFR
SCHEMBL30090884 0.91 AXL (0.80) AXLFLT3KITAURKAEGFR
SCHEMBL30090894 0.91 AXL (0.64) AXLFLT3KITAURKAEGFR
SCHEMBL2056528 0.91 AXL (0.64) AXLFLT3KITAURKAEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4125908-A1 COMBINATION THERAPY COMPRISING AN AXL INHIBITOR BerGenBio ASA (NO) 2023-02-08 EP claimed
EP-4138823-A1 METHOD OF SELECTING PATIENTS FOR TREATMENT WITH A COMBINATION OF AN AXL INHIBITOR AND AN IMMUNE CHECKPOINT MODULATOR BerGenBio ASA (NO) 2023-03-01 EP disclosed
EP-4125908-A1 COMBINATION THERAPY COMPRISING AN AXL INHIBITOR BerGenBio ASA (NO) 2023-02-08 EP disclosed